Skip to main navigation Skip to search Skip to main content

Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

Research output: Contribution to journal › Meeting abstract › peer-review

Original languageAmerican English
Pages (from-to)3948
JournalInvestigative Ophthalmology Visual Science
Volume55
Issue number13
StatePublished - Apr 30 2014

Disciplines

  • Biology
  • Ophthalmology
  • Endocrinology, Diabetes, and Metabolism
  • Anatomy

Cite this